Data as of Mar 11
| -0.11 / -2.26%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +68.07% increase from the last price of 4.76.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.